HALDOL DECANOAS

This brand name is authorized in Ecuador, France, Germany, Hong Kong SAR China, Mexico, Tunisia.

Active ingredients

The drug HALDOL DECANOAS contains one active pharmaceutical ingredient (API):

1	Haloperidol decanoate UNII AC20PJ4101 - HALOPERIDOL DECANOATE
	Haloperidol is an antipsychotic belonging to the butyrophenones group. It is a potent central dopamine type 2 receptor antagonist, and at recommended doses, has low alpha-1 antiadrenergic activity and no antihistaminergic or anticholinergic activity.
	Read more about Haloperidol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AD01	Haloperidol	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AD Butyrophenone derivatives
Discover more medicines within N05AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00550338, 00550344, 03996106, 03996112, 04658570, 04959840, 04959857, 06631233, 06631256, 06951854, 06951860, 07149308, 07149314, 07233434, 07233440, 07286608, 07286614, 08772162, 08913007, 08913065, 10072029, 15194300, 15378980, 15895652, 16769257
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.218-08-06
FR	Base de données publique des médicaments	61505095
HK	Department of Health Drug Office	18132, 21615
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	335M81
TN	Direction de la Pharmacie et du Médicament	5740056A, 5740056B